男性生殖细胞肿瘤治疗后的心血管危险因素与疾病风险
基于丹麦睾丸癌数据库的队列研究,纳入5,185例男性生殖细胞肿瘤患者及51,850名匹配正常男性,中位随访15.8年。BEP化疗后1年内CVD风险显著升高,10年后心梗和心血管死亡风险轻度增加;放疗增加远期糖尿病风险;监测组心血管风险与正常人群相当。
要点
- BEP化疗后1年内静脉血栓栓塞风险HR高达24.7,心梗和脑血管意外风险亦显著升高。
- BEP化疗10年后心梗(HR 1.4)和心血管死亡(HR 1.6)风险轻度增加。
- 放疗与远期糖尿病风险升高相关(HR 1.4),但未增加其他心血管结局风险。
核心结论
- BEP化疗与治疗开始后1年内CVD风险高度增加及随访10年后轻度增加相关。
- 放疗增加糖尿病风险但不增加 incident CVD。
- 监测随访患者的心血管疾病风险与正常人群相当。
研究设计与样本
- 基于丹麦睾丸癌数据库的队列研究,纳入5,185例男性GCC患者,按出生日期匹配1:10选取51,850名正常男性。
- 中位随访15.8年,采用Cox模型分析治疗与结局关联,癌症治疗作为时变协变量。
主要发现
- BEP治疗(n=1,819)与高血压和高胆固醇血症风险增加相关。
- BEP启动后<1年,心梗HR 6.3(95%CI 2.9-13.9)、脑血管意外HR 6.0(95%CI 2.6-14.1)、静脉血栓栓塞HR 24.7(95%CI 14.0-43.6)。
- BEP治疗1年后CVD风险降至正常水平,但10年后心梗HR 1.4(95%CI 1.0-2.0)、心血管死亡HR 1.6(95%CI 1.0-2.5)。
- 放疗(n=780)增加远期糖尿病风险HR 1.4(95%CI 1.0-2.0),其他结局无显著增加。
- 监测组(n=3,332)心血管危险因素、CVD及心血管死亡与正常人群相当。
临床怎么用
- BEP化疗后第一年内应密切监测心血管事件,尤其是静脉血栓栓塞。
- BEP化疗10年后仍需关注心梗和心血管死亡风险,长期随访管理心血管危险因素。
- 放疗患者需筛查糖尿病,监测组可按常规人群管理心血管风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the risk of cardiovascular disease (CVD) after treatment of male germ cell cancer (GCC). METHODS: Clinical data were extracted from the Danish Testicular Cancer database. For each patient, 10 men matched on date of birth were identified in the Danish normal population by risk-set sampling. Cardiovascular risk factors, CVD, and associated deaths were identified in Danish registries. The association between treatment and outcomes was analyzed by separate Cox models for each outcome. Cancer treatment was included as a time-varying covariate. RESULTS: We included 5,185 patients with GCC and 51,850 men in the normal population. Median follow-up was 15.8 years. Treatment with bleomycin-etoposide-cisplatin (BEP; n = 1,819) was associated with increased risks of hypertension and hypercholesterolemia. Hazard ratios (HRs) of CVD < 1 year after initiation of BEP treatment were as follows: myocardial infarction (HR, 6.3; 95% CI, 2.9 to 13.9), cerebrovascular accident (HR, 6.0; 95% CI, 2.6 to 14.1), and venous thromboembolism (HR, 24.7; 95% CI, 14.0 to 43.6). One year after BEP treatment, the risk of CVD decreased to normal levels, but after 10 years, increasing risks were found for myocardial infarction (HR, 1.4; 95% CI, 1.0 to 2.0) and cardiovascular death (HR, 1.6; 95% CI, 1.0 to 2.5). Radiotherapy (n = 780) increased the risk of diabetes at long-term follow-up (HR, 1.4; 95% CI, 1.0 to 2.0) but not that of other outcomes. With surveillance (n = 3,332), cardiovascular risk factors, CVD, and cardiovascular death data were comparable to that of the normal population. CONCLUSION: Treatment with BEP was associated with highly increased risks of CVD < 1 year after treatment start and mildly increased risks after 10 years of follow-up. Radiotherapy increased the risk of diabetes but not incident CVD. The risk of CVD in patients followed in a surveillance program was comparable to that of the normal population.
引用
- Lauritsen J, Hansen MK, Bandak M, et al. Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer. J Clin Oncol. 2019. PMID: 31821065. doi:10.1200/JCO.19.01180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。